Richard William Avenia

Title: Richard William Avenia: Innovator in Immunoassay Technology

Introduction

Richard William Avenia is a notable inventor based in Nutley, NJ (US). He has made significant contributions to the field of immunoassay technology, holding a total of 2 patents. His work focuses on the detection and quantification of catecholamines and phenethylamines, which are crucial in various pharmacological applications.

Latest Patents

Avenia's latest patents include an innovative immunoassay for catecholamines. This method allows for the individual assay of epinephrine and norepinephrine type catecholamines by employing an oxidation procedure. This procedure selectively converts one or more of these compounds to another form that is not bound by the antibody. By measuring the difference between the total catecholamine content and that after oxidation, it is possible to determine the quantity of individual catecholamines present in the original sample. Another significant patent is for an immunoassay for pharmacologically active phenethylamines. This patent discloses new hapten compositions useful in preparing antigens that elicit antibodies for an improved radioimmunoassay. The phenethylamines detected include catecholamines such as norepinephrine, dopamine, and epinephrine, as well as amphetamines.

Career Highlights

Richard William Avenia is currently associated with Hoffmann-La Roche Inc., where he continues to advance his research and development efforts in immunoassay technology. His work has been instrumental in enhancing the accuracy and efficiency of assays used in clinical and research settings.

Collaborations

Avenia has collaborated with notable colleagues, including Benjamin Pecherer and James Gordon Christenson. These collaborations have contributed to the development of innovative solutions in the field of immunoassays.

Conclusion

Richard William Avenia's contributions to immunoassay technology have made a significant impact in the field of pharmacology. His innovative patents and collaborations highlight his dedication to advancing scientific research and improving diagnostic methods.